Work

Preclinical Activity of the Clinical Stage Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor PRT543 in Splicing Mutant Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-148494

Authors: Leya Y Schwartz, Gaurav S Choudhary, Nandini Ramachandra, Srabani Sahu, Shanisha Gordon, Bruce Ruggeri, Diane Heiser, Peggy Scherle, Daniel Starczynowski, Amit Verma

Institutions: Children's Hospital at Montefiore, Albert Einstein College of Medicine, Montefiore Medical Center, Prelude Therapeutics Incorporated (United States), Cincinnati Children's Hospital Medical Center, Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211365253

Cites:

Cited by: 3

Related to: 10